Results 31 to 40 of about 185,906 (291)
Frontiers in Medicine, 2023 BackgroundPsoriasis is a chronic skin disease affecting approximately 3.2% of the population. The 308 nm light emitting diode (LED) is a novel, portable, and cost-effective light source, may have potential in the treatment of localized psoriasis patients
Yingyuan Yu +7 more
doaj +1 more source
Early morphea simulating patch-stage mycosis fungoides in two cases
Dermatology Reports, 2018 Morphea is a skin disorder characterized by thickening of dermis and subcutaneous tissues and loss of adnexal structures. In the early inflammatory stage of morphea, diagnostic histological findings are absent and this may lead to confusion with other ...
Hamid R. Ghasemi Basir +3 more
doaj +1 more source
Guidelines for the Diagnosis and Treatment of Psoriasis in China: 2019 Concise Edition#
International Journal of Dermatology and Venerology, 2020 . Psoriasis is an immune-mediated chronic, recurrent, systemic inflammatory disease induced by the combination of hereditary and environmental factors.
Committee of Psoriasis, Dermatology Branch, Chinese Medical Association
doaj +1 more source
Dysregulated Peripheral Invariant Natural Killer T Cells in Plaque Psoriasis Patients
Frontiers in Cell and Developmental Biology, 2022 Background: Psoriasis is a common immune-mediated skin disease that involves T-cell-mediated immunity. Invariant natural killer T (iNKT) cells are a unique lymphocyte subpopulation that share properties and express surface markers of both NK cells and T ...
Yifan Hu +25 more
doaj +1 more source
Journal of Dermatological TreatmentObjective To evaluate the effect of obesity on biologic efficacy in psoriasis across different drug classes.Methods PubMed, Embase, Web of Science, and Cochrane Library were searched from inception to March 2026.
Wenjing Zhou +5 more
doaj +1 more source
Frontiers in Medicine, 2023 Ustekinumab is a biological therapy that has been approved for treating moderate-to-severe psoriasis. Although injection site reactions, nasopharyngitis, headaches, and infections are the common adverse events associated with ustekinumab, the development
Luyang Kong +13 more
doaj +1 more source
Impairment of sexual life in patients with psoriasis.
, 2007 BACKGROUND: Sexual life can be severely affected in patients with psoriasis. However, this component is not often assessed by clinicians. OBJECTIVE: To estimate the prevalence of sexual impairment and its degree of association with clinical and ...
Abeni D +4 more
core +1 more source
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro +6 more
wiley +1 more source
Frontiers in Immunology, 2023 BackgroundPsoriasis is a chronic inflammatory skin disease with effects that extend beyond the skin. Insulin resistance (IR) has been associated with psoriasis, but it remains unclear how indicators related to the triglyceride glucose (TyG) index, which ...
Dawei Huang +13 more
doaj +1 more source
Metabolic and Fluid Biomarkers Support Microglia Activation in Amyotrophic Lateral Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Amyotrophic lateral sclerosis is an incurable neurodegenerative disease involving motor neuron degeneration and metabolic and immune dysfunction. We combined clinical data, cerebrospinal fluid biomarkers and fluorodeoxyglucose positron emission tomography with magnetic resonance imaging to investigate the role of reactive microglia in disease ...
Matteo Zanovello +10 more
wiley +1 more source